World Symposium on Doping in Sport, International Athletic Foundation, Monte Carlo (1990), 107-116. 2015 Oct;7(10):919-25 Stear SJ, Braun H, Currell K. Introduction. In: Thevis M, Geyer H, Mareck U (eds.) Drug Test Anal. Table tennis: cardiorespiratory and metabolic analysis of match and exercise in elite junior national players. Lange T, Thomas A, Walpurgis K, Thevis M. Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS. Analysis 2009, 1, 382-386 Kohler M, Franz S, Regeniter A, Ikonen A, Walpurgis K, Thomas A, Schänzer W, Thevis M: Comparison of the urinary protein patterns of athletes by 2D-gel electrophoresis and mass spectrometry – a pilot study. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Eur.J. 345 (1995) 330. Mit diesem Test, der im ersten Teil auch Fragen der WHO aufgreift, kommen Sie dem Ziel von mehr Lebensqualität ein Stück näher! Recent advances in doping analysis (12). Endocrinol. Epub 2019 Aug 15. 2016; 41, Supplement 1: S19–S21, Thevis M, Sigmund G, Gougoulidis V, Beuck S, Schlörer N, Thomas A, Kwiatkowska D, Pokrywka A, Schänzer W. Screening for benfluorex and its major urinary metabolites in routine doping controls. Doping-Realität und Recht. Biomedical side effects of doping. Thevis M, Schänzer W. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis – Potential implications for sports drug testing programs Rapid Commun. Uruguay (2017): 526-538. Nolteernsting, E., Matondo, I., Murwisi, E., Schänzer, W.: Brief report of the doping analyses during the 6th All Africa Games in Harare 1995. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) 3 (2008) 125 133 Thevis M, Schänzer W: Leistungssteigernde Substanzen im LC-MS/MS. 2012 Jan 10. Clin Chem Lab Med. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Hoffmeister T, Schwenke D, Wachsmuth N, Krug O, Thevis M, Byrnes W, Schmidt W. Erythropoietic effects of low-dose cobalt application. 2016 Sep; 408(23):6431-42. Höppner S, Schänzer W, Thevis M.: Fragmentation studies of SIRT1-activating drugs and their detection in human plasma for doping control purposes. 2009, 12, 918-924 Thevis M, Geyer H, Kamber M, Schänzer W: Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. 2013 Apr 9. Therap. Anal Chem 77(11) (2005) 3579-3585 Thevis, M., Bommerich, U., Opfermann, G., Schänzer, W.: Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry. Oslo, Norway (2009) 143 Hülsemann F, Flenker U, Machnik M, Schenk I, Cinner C, Mester J, Schänzer W: Identifizierung von Bicarbonat-Applikation bei Mensch und Pferd per IRMS. Strüder, H.K., Hollmann, W., Platen, P., Donike, M., Gotzmann, A., Weber, K.: Influence of paroxetin, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in man. Rapid Commun Mass Spectrom. Methods. Analytica Chimica Acta 2015 Oct 15;897:53-61, Thomas A, Walpurgis K, Tretzel L, Brinkkötter P, Fichant E, Delahaut P, Schänzer W, Thevis M. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. [Epub ahead of print] Piper T, Fusshöller G, Emery C, Schänzer W, Saugy M. Investigations on carbon isotope ratios and concentrations of urinary formestane. Juni 2020 um 21:53 Uhr bearbeitet. Recent advances in doping analysis (11). 2017 Dec 11. doi: 10.1002/prca.201700120. (eds.). ): Sport ist Spitze - Landessportprogramm Talentsuche und Talentförderung. Buntenkötter K, Osmers M, Schenk I, Schänzer W, Machnik M, Düe M, Kietzmann M. Pharmacokinetics and in vitro efficacy of salicylic acid after oral administration of acetylsalicylic acid in horses. Routledge, London, New York, 2015, 1-39 Sigmund G, Dib J, Tretzel L, Piper T, Bosse C, Schänzer W, Thevis M. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls. Recent advances in doping analysis (14). 2010, 398, 1207 1229 Thevis M, Gerace E, Thomas A, Beuck S, Geyer H, Schlörer N, Kearbey JD, Dalton JT, Schänzer W. Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens. Labor & More 4 (2013) 24 28 Thevis M, Krug O, Schänzer W: Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing. Thieme D, Sachs H, Thevis M: Formation of the N-methylpyridinium derivative to improve the detection of buprenorphine by liquid chromatography-mass specrometry. Recent advances in doping analysis (2). In: Peters, C., Schulz, T., Michna, H. 2011 Jul 11. Drug Test Analysis 2009, 1, 568-575 Orlovius AK, Guddat S, Parr MK, Kohler M, Gütschow M, Thevis M, Schänzer W: Terbutaline sulfoconjugate: Characterisation and urinary excretion monitored by LC/ESI-MS/MS. J. Chrommatogr. Sportverlag Strauß, Köln (2008) 73 82 Parr MK, Geyer H, Köhler K, Schänzer W: Cross-contaminations of vitamine- and mineral-tablets with metandienone and stanozolol. 2012 May 7. doi: 10.1002/dta.1361. J Steroid Biochem Mol Biol. 2016 Jun 24. doi: 10.1002/dta.2001. Toxicol Lett. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Dtsch.Apoth.Ztg. II - Electron impact fragmentations of 3-keto-en- and 3-keto-5a-steroid-17-O-glucuronides and 5a-steroid-3a,17ß-diol 3- and 17-glucuronides. Drug Test. 2020, 58, 690. Maughan RJ, Burke LM, Dvorak J, Larson-Meyer DE, Peeling P, Phillips SM, Rawson ES, Walsh NP, Garthe I, Geyer H, Meeusen R, van Loon L, Shirreffs SM, Spriet LL, Stuart M, Vernec A, Currell K, Ali VM, Budgett RGM, Ljungqvist A, Mountjoy M, Pitsiladis Y, Soligard T, Erdener U, Engebretsen L. IOC Consensus Statement: Dietary Supplements and the High-Performance Athlete. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) 2009; 32: 197-202 Mareck U, Haenelt N, Geyer H, Guddat S, Kamber M, Brenneisen R, Thevis M, Schänzer W: Temporal indication of cannabis use by means of THC glucuronide determination. Steroids, 57 (1992) 537-550. Chim. 2013, 5, 896-899 Karsten Koehler, Silvia Achtzehn, Hans Braun, Joachim Mester, and Wilhelm Schänzer: Comparison of self-reported energy availability and metabolic hormones to assess adequacy of dietary energy intake in young elite athletes. Anal Chem. Nolteernsting, E., Opfermann, G., Donike, M.: 1-(N,N-Diisopropylamino)-n-alkanes: A new reference system for systematical identification of nitrogen containing substances by gas-chromatography and nitrogen specific or mass spectrometrical detection. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Nutritional Neuroscience, 1 (1998) 419 426 Strüder, H.K., W. Hollmann, P. Platen, A. Gotzmann, K. Weber: Influence of the monoaminergic system modifications on neuroendocrine variables and physical and mental fatigue. Sport und Buch Strauß,Köln (2000) 23 32 Gotzmann, A., Komanns, B., Adib, A., Bredehöft, M., Schänzer, W.: Creatine- A doping substance ? Garzinsky A‐M, Walpurgis K, Krug O, Thevis M. Does oral fluid contribute to exhaled breath samples collected by means of an electret membrane? Lehmann S, Schulze B, Thomas A, Kamphausen T, Thevis M, Rothschild MA, Mercer-Chalmers-Bender K. Organ distribution of 4‑MEC, MDPV, methoxetamine and α‑PVP: comparison of QuEChERS and SPE. Biomed Chromatogr, 21 (2007) 164 168 Parr MK, Orlovius A, Guddat S, Gütschow M, Thevis M, Schänzer W: Sulfoconjugates of heavy volatile nitrogen containing doping substances utilizing LC-MS/MS. Recent advances in doping analysis (26). (eds.) Peptidic drugs and drug candidates in sports drug testing: agents affecting mitochondrial biogenesis or preventing activing receptor II activation. Aktuel Ernahrungsmed 2013; 38(04): 283-289 Grau M, Pauly S, Ali J, Walpurgis K, Thevis M, Bloch W, Suhr F: (2013) RBC-NOS-Dependent S-Nitrosylation of Cytoskeletal Proteins Improves RBC Deformability. Gotzmann, A., Schänzer, W., Donike, M.:The Quantification of Cortisol (Hydrocortisone) in Horse Urine by HPLC and GC/MS: Screening and Confirmation. In: Meeusen, R., Duchateau, J., Roelands, B., Klass, M., De Geus, B., Baudry, S., Tsolakidis, E. Steroids 2009: 74: 322-328 Parr MK , Laudenbach-Leschowsky U, Höfer N, Schänzer W, Diel P: Anabolic and androgenic activity of 19-norandrostenedione after oral and subcutaneous administration - Analysis of side effects and metabolism. Sportverlag Strauß, Köln (2009) 225 228 Thevis M, Hemmersbach P, Geyer H, Schänzer W: Doping im Behindertensport. Drug Test Anal. Thevis, M., Opfermann, G., Schänzer, W: High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/tandem mass spectrometry. F.I.T. Stuttgart 15.-18. 2011, 15, 2115-23. Sportverlag Strauß, Köln (2008) 233 243 Kohler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Lüdke A, Thevis M, Völker-Schänzer E, Schänzer W: Relative mobility values for the discrimination of endogenous and recombinant EPO on SDS gels. Diese Kategorie umfasst nur Cookies, die grundlegende Funktionalitäten und Sicherheitsmerkmale des Shops gewährleisten. Deutscher Sportärztekongress Paderborn 1993, Deutscher Ärzte-Verlag, Köln 1994, 541-544 STRÜDER, H.K., M. DONIKE, K. WEBER, W. HOLLMANN: Changes in concentrations of plasma amino acids during a 4 h tennis match and their effect on brain neurotransmitters. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) GIT Labor-Fachzeitschrift. Sport und Buch Strauß, Köln (1998) 209-214. Völker-Schänzer E, Majer B, Kempkes R, Reihlen P, Thomas A, Thevis M, Schänzer W: An efficient sample preparation for CERA analysis in serum. 32 (2008) 232 240 Thevis M, Kohler M, Schlörer N, Schänzer W: Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation. Thomas A, Thevis M. Recent advances in the determination of insulins from biological fluids. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Koehler K, De Marees M, Braun H, Schaenzer W. Evaluation of two portable sensors for energy expenditure assessment during high-intensity running, European Journal of Sport Science 2011 (epub ahead of print) DOI:10.1080/17461391.2011.58643 Koehler K, Braun H, Marees M, Geyer H, Thevis M, Mester J, Schaenzer W: Urinary excretion of exogenous glycerol administration at rest. A screening method for nortestosterone in horse serum wit a possible confirmation in urine. Proceedings of the 19th International Conference of Racing Analysts and Veterinarians 2012, Philadelphia, USA (2015) 115 -124. Schröder H, Gebhardt W, Thevis M. Anabolic, doping, and lifestyle drugs, and selected metabolites in wastewater-detection, quantification, and behaviour monitored by high-resolution MS and MS( n ) before and after sewage treatment. So far, more than 17 000 persons aged 6 to 25 years have participated in the Fit for Life study. Rapid Communications in Mass Spectrometry 2020 Apr 15;34 (7), König D, Braun H, Carlsohn A, Großhauser M, Lampen A, Mosler S, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Ziegenhagen R, Heseker H. Position of the working group sports nutrition of the German Nutrition Society (DGE): carbohydrates in sports nutrition. Book of Abstracts des "Joint Meeting of the Austrian and German Pharmaceutical Societies: Shaping the future – Trends and perspectives in pharmaceutical sciences", 20.–23.09.2011, Innsbruck, Austria. Möller I, Thomas A, Geyer H, Schänzer W, Thevis M: Detection and method validation of peginesatide in human serum by means of LC-MS/MS. Internationaler Workshop Sportgesspräch 16.17.02.2003 Oberhausen. Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 141-152. Recent advances in doping analysis (18). In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) J.Mass.Spectrom. Thevis M, Piper T, Geyer H, Thomas A, Schaefer M, Kienbaum P, Schänzer W: Measuring xenon in human plasma and blood by gas chromatography/mass spectrometry. Mohr Siebeck, Tübingen, 2010, 13-21 Thevis M, Möller I, Thomas A, Beuck S, Rodchenkov G, Bornatsch W, Geyer H, Schänzer W: Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls. Sofia, 8-10 October (1998) 44. In: Cable, N.T. Sportverlag Strauß, Köln (2009) 301 304 Machnik M, Kaiser S, Koppe S, Kietzmann M, Toutain PL, Schenk I, Düe M, Guddat S, Schänzer W: Pharmacokinetic data of methylxanthines in horses after iv and oral administration of caffeine, theobromine and theophylline. Recent advances in doping analysis (9). 2012 Nov 15. Ines Möller, Annette Wintermeyer, Katja Bender, Martin Jübner, Andreas Thomas, Oliver Krug, Wilhelm Schänzer, Mario Thevis: Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test Anal. 2016 Apr 15;30(7):982-4. Mareck-Engelke U., Geyer H. and Donike M.: Stability of steroid profiles (2): Excretion rates from morning urines. Schänzer W.: The illegal use of anabolic agents in sports. In: Houghton E, Kijima-SudaI, Wade JF (eds.) Flenker, U., Güntner, U. Schänzer, W.:13C/12C-Measurment of 17-Ketosteroids to detect abuse of androgenic steroids in sport. Recent advances in doping analysis (5). Abstractband. Recent advances in doping analysis (5). Die Trainerakademie Köln. Josef Dib, Nils Schlörer, Wilhelm Schänzera and Mario Thevisa, Studies on the collision-induced dissociation of adipoR agonists after electrospray ionization and their implementation in sports drug testing. Current Proteomics, 3 (2005) 191 208 Thevis, M., Schänzer, W.: Designer-Steroide und Dopinganalytik - Modifizierte Steroidhormone erfordern neue Nachweismethoden. Paper: Liphardt AM, Mündermann A, Koo S, Bäcker N, Andriacchi TP, Zange J, Mester J, Heer M. (2009): Vibration training intervention to maintain cartilage thickness and serum concentrations of cartilage oligometric matrix protein (COMP) during immobilization. Anna schmeißt die Uni ... Köln 50667 (Folge 1949) Fr, 11.09.2020, 18:09 Recent advances in doping analysis (15). Recent advances in doping analysis (13). Strüder, H. Herzog, H.-G. Fischer, P. Platen, K. De Meirleir, M. Donike: Gehirn - hämodynamische, metabolische und psychische Aspekte bei körperlicher Arbeit. Mass. Aufl. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Am., 2010, 39, 45-57 Piper T, Geyer H, Schänzer W. Degradation of urine samples and its influence on the (13) C/(12) C ratios of excreted steroids. Thevis, M., Opfermann, G., Schänzer, W: Mass spectrometry of partially methylated alditol acetates derived from hydroxyethyl starch. Drug Test. UEFA expert group 2020 statement on nutrition in elite football. Recent advances in doping analysis (15). Recent advances in doping analysis (14). Recent advances in doping analysis (14). 2018 Sep 19;9:1289. doi: 10.3389/fphys.2018.01289. Mass Spectrom. Sportverlag Strauß, Köln (2009) 277 280 Van Renterghem P, Van Eenoo P, Geyer H, Schänzer W, Delbeke FT: Alternative steroid profiling: Reference ranges for urinary endogenous steroids in a caucasian population of athletes. Gaunitz F, Thomas A, Fietzke M, Franz F, Auwärter V, Thevis M, Mercer-Chalmers-Bender K. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (2). Recent advances in doping analysis (16). Gotzmann, A., Platen, P., Keizer,, H.A., Donike, M., Velde, C., Heps, U., Dobberstein, C.: Exercise induced changes of serum tryptophan (TRP) and the large-neutral-aminoacids (LNAA) and their relation to prolactin (PRL) release in trained women. The status of two boreo-alpine species, Somatochlora alpestris and S. arctica, in Romania and their vulnerability to the impact of climate change (Odonata: Corduliidae). (eds.). Sportverlag Strauß, Köln (2015) 126 129. Deutscher Ärtzteverlag, Köln (2012) S.189-196 Krug O, Thomas A, Walpurgis K, Sigmund G, Schänzer W, Thevis M: Analysis of confiscated products with suspiciously doping relevant ingredients by GC-MS, LC-HRMS and LC-MSn. Koehler K, Huelsemann F, de Marees M, Braunstein B, Braun H, Schaenzer W. Case Study: Simulated and real-life energy expenditure during a three-week expedition. Schänzer, W. Thevis, M.: Doping und Dopinganalytik. 2019 Jul;133(4):1049-1064. Sportverlag Strauß, Köln (2009) 261 264 Gotzmann A, Grosse j, Schänzer W: Detection of total ß-hCG in doping control – A case study. Mit diesem Test, der im ersten Teil auch Fragen der WHO aufgreift, kommen Sie dem Ziel von mehr Lebensqualität ein Stück näher! Clinical Chemistry, 42 (1996) 1001-1020 Seinsch, I., Sigmund, G., Horning, S., Donike, M.: Detection of salbutamol in horse urine. In: Thieme D, Hemmersbach P (eds.) Recent advances in doping analysis (9). Sportverlag Strauß, Köln (2011) 100 Piper T, Fußhöller G, Schänzer W: Investigations on the deconjugation processes of conjugated urinary steroids during degradation with 18O labelled water. Sportverlag Strauß, Köln (2010) 109 117 Thomas A, Beuck S, Eickhoff JC, Guddat S, Krug O, Kamber M, Schänzer W, Thevis M: Quantification of urinary AICAR concentrations as a matter of doping controls. Appl. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Energy balance and food sources during an ultra endurance cycling event. ): Terra Nostra - Schriften der GeoUnion Alfred-Wegener-Stiftung 09/03, Brandenburgische Universitätsdruckerei und Verlagsgesellschaft, Potsdam, 2009, 65 Piper T, Flenker U, Mareck U, Schänzer W: 13C/12C Ratios of endogenous urinary steroids investigated for doping control purposes. Braun H, von Andrian-Werburg J, Malisova O, Athanasatou A, Kapsokefalou M, Ortega JF, Mora-Rodriguez R, Thevis M. Differing Water Intake and Hydration Status in Three European Countries—A Day-to-Day Analysis. Sportverlag Strauß, Köln (2012) 132 134 Krug O, Thomas A, Beuck S, Schenk I, Machnik M, Schänzer W, Bondesson U, Hedeland M, Thevis M. Characterization of In Vitro Synthesized Equine Metabolites of the Selective Androgen Receptor Modulators S24 and S4. ): Doping. Handbook of Experimental Pharmacology 195, Springer, Heidelberg, Dordrecht, London, New York, 2010, 201-207 Thevis M, Schänzer W: Synthetic anabolic agents: Steroids and nonsteroidal selective androgen receptor modulators. In: M. Gamper, J. Mühlethaler, F. Reidhaar (eds. Recent advances in doping analysis (2). Anal Bioanal Chem (2010) 398:1305-1312 Abstract Figure explaning a possible doping effect of siRNA Kohler M, Thomas A, Walpurgis K, Terlouw K, Schänzer W, Thevis M. Detection of His-tagged Long-R(3)-IGF-I in a black market product. Sport und Buch Strauß, Köln, (2000) 69 78 Geyer, H., Henze, M.K., Mareck-Engelke, U., Sigmund, G., Schänzer, W.: Analysis of nutritional supplements for dope substances. Anal Bioanal Chem, online 2010, DOI 10.1007/s00216-010-4589-4 Schänzer W. Neuroenhancement – Doping fürs Gehirn – Ein Thema für Sportstudierende? Blood samples in doping control. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Möller I, Wintermeyer A, Thomas A, Krug O, Bender K, Schänzer W, Thevis M: In-vitro metabolism of the synthetic cannabinoid JWH-018 and implementation of its major metabolites in human doping controls. (eds.). Sportverlag Strauß, Köln (2019) 30 34, Schek A, Braun H, Carlsohn A, Großhauser M, König D, Lampen A, Mosler S,Nieß A, Oberritter H, Schäbethal K, Stehle P, Virmani K, Ziegenhagen R, Heseker H. Position of the working group sports nutrition of the German Nutrition Society (DGE): fats, fat loading, and sports performance. Drug Test Anal. PMID: 33097528. Sport und Buch Strauß, Köln (2001) 187 190 Flenker, U., Schänzer, W.: Caffeine in Doping Control: Determination of 13C in urinary excreted caffeine. Abstractband. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) 2013 Jul 23. Sport und Buch Strauß, Köln (1998) 259-268. Epub 2015 Nov 11. JESIUM (2004) 10 Hebestreit, M., Flenker, U., Schänzer, W.: Hardware-considerations of purification of steroids by normal-phase HPLC for GC-C-IRMS. A.: Mass spectrometric characterization of transferrins and their fragments derived by reduction of disulfide bonds. Medicine & Science in Sports & Exercise 2010, 5, S304-5 Kohler M, Gotzmann A, Görgens C, Flenker U, Thevis M, Schänzer W: Comparison of hGH serum concentrations of Caucasian and African top athletes: an ethnicity study. 2013, 27, 1173–1182. 2011 Jan; 3(1):1-14. Recent advances in doping analysis (2). In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Anal Bioanal Chem. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Fitnessstudio-Test: So finden Sie das passende Fitness-Angebot Teilen dpa/Tobias Hase/dpa-tmn Moderne Geräte oder mehrere Saunen - Fitnessstudios überbieten sich … In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (17). König D, Carlsohn A, Braun H, Großhauser M, Lampen A, Mosler S, Nieß A, Schäbethal K, Schek A, Virmani K, Ziegenhagen R, Heseker H: Proteins in sports nutrition. A. Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis. Sport und Buch Strauß, Köln (1995) 269-274. Proceedings of the joint European stable isotope users group meeting. Rapid Commun. Proceedings of the Sport nutrition conference, Munich 2009. In: Joint meeting of the Czech, German and Hungarian pharmaceutical societies. Anal. Res. Sport und Buch Strauß, Köln (2004) 65 68 Mareck, U., Sigmund, G., Opfermann, G., Geyer, H., Schänzer, W.: Screening on letrozoleand ist metabolite in doping analysis. . Recent advances in doping analysis (7). Thomas A, Thevis M. Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry. Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls. Rapid Commun. Frau und Hochschule. Sportverlag Strauß, Köln (2008) 71 72 Guddat S, Thevis M, Schänzer W: Identification and quantification of the osmodiuretic mannitol in urine for sports drug testing using gas chromatography-mass spectrometry. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Sport und Buch Strauß, Köln (1998) 301 Berschick, P., Geyer, H., Schänzer, W.: Individualization of urine samples in doping control by steroid profiling and PCR based DNA analysis. [Epub ahead of print] Guddat S, Fußhöller G, Geyer H, Thomas A, Braun H, Haenelt N, Schwenke A, Klose C, Thevis M, Schänzer W. Clenbuterol-regional food contamination a possible source for inadvertent doping in sports. Recent dvances in doping analysis (26). Eur. vet. Organogenesis, 4 (2008) 230-237. Metab. 40. J. Anal. Sportverlag Strauß, Köln (2007) 21 30 Lüdke S, Sauer M, Paul M, Schänzer W: The Cologne import information system: A tool to highlight long term trends in the Black Market for drugs and doping substances. Gas Chromatography/Combustion/Isotope Ratio Mass Spectrometry of Trace Amounts of Urinary Norandrosterone. 2011, 41, 81-90. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (25). Sportverlag Strauß, Köln (2007) 293 302 Thomas A, Thevis M, Delahaut P, Bosseloir A, Schanzer W: Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. Drug Test Anal. Recent advances in doping analysis (16). Anal Bioanal Chem. Journal of Chromatography B, 687 (1996) 93 108. J Appl Physiol (1985). In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Dtsch. Rapid Commun Mass Spectrom. Rapid Commun. IPN-Test ® - Ausdauertest für den Fitness- und Gesundheitssport . Sport und Buch Strauß, Köln (2006) 403 406 Kohler M, Parr MK, Opfermann G, Schaenzer W:Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone. 2017 Jul 30;31(14):1175-1183. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Sport und Buch Strauß, Köln (2002) 35 50 PDF-file Parr, M.K., Geyer, H., Reinhart, U., Schänzer, W.:Approaches towards an Improved Analysis of Nutritional Supplements for Anabolic Androgenic Steroids. and Vets. 36 (2001) 998 1012. 12, (2006) 129 136 Thevis, M., Thomas, A., Delahaut, P., Bosseloir, A., Schänzer, W.: Doping Control Analysis of Intact Rapid-Acting Insulin Analogues in Human Urine by LiquidChromatography-Tandem Mass Spectrometry. 2017 Aug 15;31(15):1290-1296. Both test disciplines are elements of the Basis-Fitness-Test (BFT) . Horning, S., Schänzer, W.: Steroid screening using GC/HRMS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Sportverlag Strauß, Köln, 2017, 37-40. [Epub ahead of print] Thevis M, Piper T, Horning S, Juchelka D, SchänzerW. Recent advances in doping analysis (12). In Impulse, Das Wissenschaftsmagazin der Deutschen Sporthochschule Köln, 02 (2015) 38 45 Forsdahl G, Erceg D, Geisendorfer T, Turkalj M, Plavec D, Thevis M, Tretzel L, Gmeiner G. Detection of testosterone esters in blood. In: AWI – Alfred Wegener Institute for Polar and Marine Research, Research Unit Potsdam (ed. Recent advances in doping analysis (8). 2016. Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (1995) 113-120. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Das Wissenschaftsmagazin der Deutschen Sporthochschule Köln,2016, 01, 37-43, Walpurgis K, Thomas A, Vogel M, Reichel C, Geyer H, Schänzer W, Thevis M. Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of Western blotting and LC-HRMS. Braun, H; de Marees, M; Mester, J; Thevis, M; Schaenzer, W. (2014). JESIUM (2004) 11 Machnik, M., Düe, M., Parr, M., von Kuk, C., Schänzer, W.: Case study: Doping substances in equestrian food supplements. International Journal of Sports Physiology and Performance. After pre-test, patients were randomly assigned in equal numbers to the HG or the NG. Piper T, Geyer H, Gougoulidis V, Flenker U, Schänzer W. Determination of 13C/12C ratios of urinary excreted boldenone and its main metabolite 5beta-androst-1-en-17beta-ol-3-one. 2018 Dec 1;81:28-35. doi: 10.1016/j.niox.2018.10.003. Leichtathletiktraining, 2018, (29), 8, 28-33. In: Thieme D, Hemmersbach P (eds.) A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. Drug Test Anal. 2015 Jun;407(16):4709-20, Vogel M, Thomas A, Schänzer W, Thevis M. EPOR-Based Purification and Analysis of Erythropoietin Mimetic Peptides from Human Urine by Cys-Specific Cleavage and LC/MS/MS. Orlovious AK, Guddat S, Parr MK, Koch A, Gütschow M, Thevis M, Schänzer W: Identification and Monitoring of octopamine sulfoconjugate in urine by LC/(ESI)-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Mareck-Engelke, U., Flenker, U., Schänzer, W.: Stability of steroid profiles (6) Influence of oral contraceptives on steroide profiles. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Eur. In: D. Lagerstrom, G. Uhlenbruck (eds. R & W publications, Newmarket (2004) 429 433 Thevis, M., Opfermann, G., Schänzer, W.: N-methyl-N-trimethylsilyltrifluoroacetamide-promoted synthesis and mass spectrometric characterisation of deuterated ephedrines. Schänzer, W., Delahaut, P., Völker, E., Donike, M.: Immunoaffinity chromatography in isolation of anabolic steroids. Int. [Epub ahead of print] Thevis M, Thomas A, Schänzer W. Doping control analysis of selected peptide hormones using LC-MS(/MS). [Epub ahead of print] Machnik M, Fußhöller G, Schenk I, Wagner S, Wingender A, Thevis M, Schänzer W. Multi-target screening of unconjugated, volatile and alkaline drugs in horse blood and urine using GC-MS/MS in SRM-full SCAN mode. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) J. 2011 Dec;21(6):520-6 Koehler K, Braun H, Schänzer W: Einsatz von Nahrungsergänzungsmitteln im Sport.
Threema Update Amazon, Kantine Konstanz Mittagstisch, Botschaft Ungarn Berlin, Aok Beitragsbemessungsgrenze 2020, Harvest Moon - Großbasar Heiratskandidaten, Ozark Staffel 1 Besetzung, Zufahrt Nauders Aktuell,
Leave a Comment